Phase III trial for a topical whole body treatment for EB patients with Simplex, Recessive Dystrophic and Junctional EB
Join Sharmila as she talks to Dr Robert Ryan, Founder and CEO of Paradigm Therapeutics about a phase III clinical trial for a topical cream they are developing.
When? Wednesday 23rd September, 1.30pm BST
Where? Online – register now
Who? This webinar is open to all – EB patients and families, researchers, clinicians, and anyone with an interest in EB. The webinar is free to join.

